Cantourage Group SE

€5.28As of Sun 8 Nov 2026, 12:00 UTC
XETRA:HIGHHealthcare
Country Germany
PE (Fwd) •••
TSR 4Y CAGR (25.23%)
Div yield —
ROE 0.41%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.01)
PE TTM 353.0
TSR TTM 74.26%
Mkt cap €65.84M
ROIC 0.40%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€6.22
17.81%
(90.26%)
Sell 6|2|5|2|11
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.06
0.06
0.06
0.06
17.01%
24.17%
23.07%
14.39%
Revenue€M
3.367
3.525
3.520
3.471
14.31%
17.89%
14.48%
8.85%
Peers (US$73.93M)
Cap (US$)
PE
631.5M
—
121.6M
—
20.61M
3.497x
74.06M
14.35x
Capital
TTM
5Y
10Y
Leveragex
0.420
(0.409)
(0.351)
EBIT/Intx
0.526
0.167
0.170
Own earn%
46.14
231.99
177.19
Sh yield%
21.72
34.31
40.86
Owners
Insiders/Inst%
13.85
84.53
Short interest%
3.31
SBC / revenue%
1.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
6–13
$1 testx
−0.1
Incr. ROIC%
0